Impact of timing of immunotherapy in survival among patients with advanced lung adenocarcinoma treated with first-line immunochemotherapy: A propensity score matching

被引：0
|
作者：
Sun, Yanxin
Wang, Leirong
Sun, Yuping
Dang, Qi
Ge, Yihui
Gao, Aiqin
Cheng, Qinglei
Sun, Haifeng
Zhang, Jian
Wu, Jiake
Li, Juan
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Phase 1 Clin Res Ctr, Jinan, Shandong, Peoples R China
[2] Shandong Canc Hosp, Jinan, Peoples R China
[3] Shandong Univ Canc Ctr, Phase 1 Clin Res Ctr, Jinan, Shandong, Peoples R China
[4] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Thorac Radiat Oncol, Jinan, Peoples R China
[5] Shandong Second Med Univ, Weifang, Shandong, Peoples R China
[6] Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[7] Shandong First Med Univ, Jinan, Shandong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20560
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Baseline Tumor Size and Survival Outcomes among Patients with Advanced NSCLC treated with First-Line Immunotherapy
    Uehara, Y.
    Hakozaki, T.
    Kitadai, R.
    Hosomi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S392 - S392
  • [2] Impact of first-line treatment response on second-line therapy with nintedanib plus docetaxel in advanced lung adenocarcinoma after combined first-line immunochemotherapy
    Grohe, C.
    Wehler, T.
    Henschke, S.
    Dittrich, I
    Hammerschmidt, S.
    Aulmann, C.
    Dechow, T.
    Schiefer, C.
    von der Heyde, E.
    Schuette, W.
    Atz, J.
    Kaiser, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 208 - 208
  • [3] Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy
    Perrone, A. Leonetti F.
    Puntoni, M.
    Bordi, P.
    Maglietta, G.
    Carpana, C.
    Gelsomino, F.
    Passiglia, F.
    Genova, C.
    Montrone, M.
    Caliman, E.
    Cerea, G.
    Pasello, G.
    Cecere, F.
    Manzo, A.
    Adamo, V.
    Citarella, F.
    Toschi, L.
    Gelibter, A.
    Rastelli, F.
    Carta, A.
    Guida, A.
    Camerini, A.
    Paoloni, F.
    Bertolini, F.
    Tiseo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S338 - S339
  • [4] Efficacy of radiotherapy in combination with first-line immunotherapy and chemotherapy for advanced lung squamous cell carcinoma: a propensity score analysis
    Qin, Jian
    Yi, Shouhui
    Zhou, Hanjing
    Zeng, Chuan
    Zou, Minghua
    Zeng, Xuan
    Yang, Zhenzhou
    Huang, Yusheng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program
    J. Corral
    M. Majem
    D. Rodríguez-Abreu
    E. Carcereny
    Á. A. Cortes
    M. Llorente
    J. M. López Picazo
    Y. García
    M. Domine
    M P. López Criado
    Clinical and Translational Oncology, 2019, 21 : 1270 - 1279
  • [6] Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program
    Corral, J.
    Majem, M.
    Rodriguez-Abreu, D.
    Carcereny, E.
    Cortes, A. A.
    Llorente, M.
    Lopez Picazo, J. M.
    Garcia, Y.
    Domine, M.
    Lopez Criado, M. P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (09): : 1270 - 1279
  • [7] Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter study
    Zhou, YuBin
    Huang, Jian
    Lan, Jun
    Hu, Hao
    Yuan, Zihao
    Dong, Longyan
    Deng, Huiyin
    Yue, Li-ao
    Xiao, Yi
    Yang, Xiongwen
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (04) : 1011 - 1018
  • [8] Clinical Characteristics and Outcome for Patients with Advanced Lung Adenocarcinoma Treated with First-Line Pemetrexed Plus Platinum
    Ji, X.
    Hu, X.
    Zhu, Y.
    Liu, Y.
    Lin, L.
    Xing, P.
    Hao, X.
    Wang, Y.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S885 - S885
  • [9] Impact of Depth of Response (DpR) on Survival in Patients with Advanced NSCLC Treated with First-Line Chemotherapy
    Morgensztern, Daniel
    O'Brien, Mary
    Ong, Teng
    Socinski, Mark
    Postmus, Pieter
    Ko, Amy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S387 - S388
  • [10] Effect of intrathecal pemetrexed on survival in patients with lung adenocarcinoma with leptomeningeal metastasis: A propensity score matching analysis
    Hong, Yaping
    Miao, Qian
    Zhuang, Wu
    Zheng, Xinlong
    Huang, Zhangzhou
    Xu, Yiquan
    Lin, Gen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345